Psychosocial Aspects of Living With Diabetes Mellitus: An Enhancement of Diabetic Program of Primary Health Care in Doha, Qatar

Diabetes mellitus has a detrimental impact on one's well-being. Psychological and social aspects play a significant role in diabetes care and it is believed that these issues are important in the overall health of Qatari patients with diabetes mellitus. This descriptive cross-sectional research was conducted to determine the psychological and social aspects of living with diabetes mellitus. Two hundred eighty patients with diabetes mellitus were included as respondents of the study. It has shown that the respondents were, in general, psychologically and socially well. They were satisfied with their own selves and lived in a purposeful manner, however, they were anxious about the complications of the disease. Family members were concerned about their condition wherein they could talk freely about diabetes mellitus. Educational attainment and living arrangement were significantly correlated with psychological well-being. Presence of illnesses not related to diabetes was significantly correlated with both psychological and social well-being. To conclude, despite having diabetes mellitus, the patients still feel good about themselves, maintain healthy relationships and exhibit good psychological health and social well-being. To achieve the goals of diabetes care and to meet the challenges of diabetes, psychosocial interventions should be included as part of ongoing diabetes management. Keywords: diabetes mellitus; psychosocial aspect of diabetes mellitus; diabetic program; primary health car

SARS-CoV-2 infection among primary healthcare workers: a cross- sectional study

Healthcare workers (HCWs) are critical to the healthcare system and are at an increased risk of SARS-CoV-2 infection. They may acquire infections from the community and their work settings. To date, the majority of the studies reporting on the epidemiology of SARS-CoV-2 infections in HCWs, including serology testing, are from hospital settings. Primary care provides a platform and plays a critical role in prevention, testing, triaging and treating patients, but a smaller number of studies focus on primary care settings. In a recent systematic review, primary care physicians were at increased risk of worse outcomes and were the highest risk specialty for deaths among doctors. This short report provides an objective assessment of infection risk among frontline primary care HCWs utilizing RT-PCR results and serology testing

Additional file 1: of Diabetes Intervention Accentuating Diet and Enhancing Metabolism (DIADEM-I): a randomised controlled trial to examine the impact of an intensive lifestyle intervention consisting of a low-energy diet and physical activity on body weight and metabolism in early type 2 diabetes mellitus: study protocol for a randomized controlled trial

SPIRIT 2013 Checklist: Recommended items to address in a clinical trial protocol and related documents*. (DOC 124 kb

Diabetes Intervention Accentuating Diet and Enhancing Metabolism (DIADEM-I):a randomised controlled trial to examine the impact of an intensive lifestyle intervention consisting of a low-energy diet and physical activity on body weight and metabolism in early type 2 diabetes mellitus: study protocol for a randomized controlled trial

Abstract Background Type 2 diabetes mellitus (T2DM) and obesity are syndemic and will have a significant impact on affected individuals and healthcare services worldwide. Evidence shows that T2DM remission can be achieved with significant weight loss in those who are younger with early diabetes and requiring fewer medications for glycaemic control. DIADEM-I aims to examine the impact of an intensive lifestyle intervention (ILI) using a low-energy diet (LED) meal replacement approach combined with physical activity in younger individuals with early T2DM. Methods The planned study is an ongoing, non-blinded, pragmatic, randomised controlled, parallel-group trial examining the impact of an LED-based ILI on body weight and diabetes remission in younger (18–50 years) T2DM individuals with early diabetes (≤ 3-year duration). The ILI will be compared to usual medical care (UMC). The primary outcome will be weight loss at 12 months. Other key outcomes of interest include diabetes remission, glycaemic control, diabetes complications, cardiovascular health, physical activity, mental health, and quality of life. It is planned for the study to include 138 subjects for assessment of the primary outcome. Safety will be assessed throughout. Discussion If DIADEM-I demonstrates a clinically significant effect for younger individuals with early T2DM, it will inform clinical guidelines and services of the future for management of T2DM. Trial registration ISRCTN: ISRCTN20754766 (date assigned: 7 June 2017); ClinicalTrials.gov, ID: NCT03225339 Registered on 26 June 2017